WHO ICTRP trial
A randomized, open-label, single dose, two-way crossover design bioequivalence…
TCTR20231012005 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20231012005 |
|---|---|
| Public title | A randomized, open-label, single dose, two-way crossover design bioequivalence study with two-periods, two-treatments, and two-sequences of Tadalafil 20 mg relative to Cialis 20 mg , Eli Lilly Nederland B.V. |
| Scientific title | A randomized, open-label, single dose, two-way crossover design bioequivalence study with two-periods, two-treatments, and two-sequences of Tadalafil 20 mg Film-coated Tablets relative to Originator Cialis 20 mg Film-coated Tablets, Eli Lilly Nederland B.V., under fed condition in compliance with EU… |
| Primary sponsor | Bio-innova Co., Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | Healthy subjects Bioequivalence Tadalafil 20 mg Film-coated Tablets;Bioequivalence Tadalafil 20 mg Film-coated Tablets |
| Interventions | The new generic products which were recently developed. Volunteer will receive a single dose of Tadalafil 20 mg Film-coated Tablets with 250 mL of drinking water.,The marketed original products which were already available in the market… |
| Registration date | Dec 10, 2023 |
| Target size | 30 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: